ClinicalTrials.Veeva

Menu

Multi-omics Study on Gut Microbiota in Critical Ill Patients After Cardiopulmonary Bypass (CPB-MUL-GM)

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Unknown

Conditions

Cardiopulmonary Bypass
Sepsis

Treatments

Procedure: extracorporeal circulation during cardiac surgery

Study type

Observational

Funder types

Other

Identifiers

NCT04032938
ZS-1612

Details and patient eligibility

About

Using metagenomics as well as metabolomics, the variation of the gut microbiota and host metabolite profiles of patient after undergoing CPB were explored.

Full description

This protocol is designed as a prospective observational case-control study in patients who underwent cardiopulmonary bypass (CPB) due to cardiac surgery. 30 healthy persons were selected as control group. The case group included patients admitted to intensive care unit (ICU) after cardiac surgery and extracorporeal circulation which is performed by the Department of cardiac surgery of Peking Union Medical College Hospital. The patients enrolled should be divided into two groups according to their primary outcomes: one grouped fever and/or hemodynamic instability after cardiopulmonary bypass and the other grouped normothermia and normal hemodynamic during 48 hours after surgery(cause an infection manifested >48 hours after admission was defined as hospital acquired. ). Sample collection was terminated when both groups received 30 cases. These 60 cases would regard as the case group. Additionally, all the CPB patients we observed will be divided into survivors and non-survivors based on the 28-day survival. Feces and blood samples will be obtained at certain time points(initial sampling at least one day before the surgery, repeat sampling within 24-48 hours after CPB). The fecal samples analysis will apply metagenomics and the feces and blood samples will be analyzed using untargeted metabolomics method. In this study, the stratification of gut microbial communities in patients underwent extracorporeal circulation were explored and analysed the variation of metabolite in patients's plasma and fecal samples. Predictive bio-markers and possible pathogenesis of fever and/or hemodynamic instability after CPB will be also provided by clinical outcomes analysis combined with multi-omics study.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients will be admitted to ICU between 18 and 85 years of age who will undergo extracorporeal circulation during cardiac surgery and provided written informed consent will be enrolled as candidates of case group.
  • Healthy volunteers will be enrolled as control group.

Exclusion criteria

  • Patients had a fever before surgery, regardless of the etiological evidence of infection;
  • had anti-infective treatment before surgery;
  • had gastrointestinal surgery which left the digestive system dysfunctional;
  • had a history of CPB in 6 month;
  • reject or abandon ICU therapeutic intervention.

Trial design

150 participants in 2 patient groups

the control group
Description:
30 healthy people as the control group.
the case group
Description:
60 patients were admitted to intensive care unit (ICU) as the case group after cardiac surgery and extracorporeal circulation. This group should contain 30 patients with fever and/or hemodynamic instability and 30 patients with normothermia and normal hemodynamic.
Treatment:
Procedure: extracorporeal circulation during cardiac surgery

Trial contacts and locations

1

Loading...

Central trial contact

Wenyan Ding, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems